Research
Genzyme Oncology’s commitment to innovation continues with research and development programs focused on the hematologic oncology field, as well as on the development of new therapies for solid tumors. An ongoing discovery program utilizes a broad range of target discovery, target validation and drug development technologies. Genzyme Oncology is also working in active collaboration with partner companies and academic institutions. In particular the combination of new, sophisticated molecular diagnostics with targeted therapeutics is considered hopeful in revolutionizing cancer treatment and improving patient outcomes.